Evidence map›Paper›PMID 39554306›Full record

ArticleFrontiers in pediatrics2024

Association of recent antibiotic exposure and coronary artery lesions in Kawasaki disease: nationwide study.

Hideto Ansai, Masaki Yamada, Hiroshi Masuda, Ken-Ichi Imadome, Mayumi Yashiro, Magali Noval Rivas, Moshe Arditi, Yosikazu Nakamura, Jun Abe

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. [Gut-vascular axis in Kawasaki disease: short-chain fatty acid-mediated immune regulation and therapeutic targets].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Gut Microbiota Alterations in Patients With Kawasaki Disease.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hideto AnsaiDepartment of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
Masaki YamadaDepartment of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
Hiroshi MasudaDepartment of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
Ken-Ichi ImadomeDepartment of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
Mayumi YashiroDepartment of Public Health, Jichi Medical University, Tochigi, Japan.
Magali Noval RivasDepartment of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Moshe ArditiDepartment of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Yosikazu NakamuraDepartment of Public Health, Jichi Medical University, Tochigi, Japan.
Jun AbeDepartment of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the relationship between recent antibiotic exposure and the development of coronary artery lesions (CALs) during the clinical course of Kawasaki disease (KD). Design: Data were obtained from the 25th nationwide epidemiological survey of KD conducted in Japan from 2017 to 2018. Baseline characteristics and clinical course were compared between Antibiotics (+) and Antibiotics (-) groups. Setting: Nationwide survey of KD in Japan. Participants: KD patients were enrolled by response to a questionnaire sent to physicians working in pediatrics at hospitals with >100 beds. Exposure: Antibiotic exposure within one week before the first hospital visit as KD patients. Main outcome measures: The relationship between recent antibiotic exposure and the development of coronary artery lesions (CALs). Results: Out of 28,265 KD patients, 12,918 (45.7%) received antibiotics. In KD patients who received antibiotics in the week before KD diagnosis, the frequency of coronary artery lesions (CALs) at each phase were significantly higher compared to those who did not receive antibiotics. In further analysis using propensity score matching, recent antibiotic exposure and the initial IVIG resistance were associated with CALs at the acute and the sequelae phase. After adjusting for the status of initial IVIG resistance, recent antibiotic exposure remained associated with CALs during the acute phase (adjusted OR 1.29, 95%CI 1.16, 1.43) and the sequelae phase (1.26, 95%CI 1.04, 1.52). Conclusions: These observations suggest that recent antibiotic exposure might be associated with higher frequency of CAL development in KD patients, possibly by altering the gut microbiota and diminishing beneficial bacteria.

Indexed as

antibioticscoronary artery lesionsgut microbiotaKawasaki diseasenationwide surveillance

Identifiers

PMID39554306
PMCPMC11563978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.